Our recent webinar series, ‘Unlocking Precision Oncology’s Full Potential through Next-Gen Molecular Analysis’, showcased cutting-edge advances in diagnostics, molecular profiling […]
Antimicrobial resistance (AMR) is one of the most pressing public health threats we will face in our lifetimes. In fact, […]
‘Dialling down bacterial resistance’ – Written by Charlotte Harrison, Science Writer. A paper published in Science Advances has identified a […]
Written by Charlotte Harrison, Science Writer Non-small cell lung cancer (NSCLC) is often associated with activating mutations in receptor tyrosine […]
In a recent study, published in the journal eLIFE, researchers have screened over 160,000 bacterial genomes to identify the presence […]
A new study published in Science suggests that targeting pyroptosis, a type of programmed cell death, may be a promising […]
Researchers have identified a new form of antimicrobial resistance (AMR) in Group A Streptococcus (GAS). GAS organisms can cause various […]
New research discovers genomic and epigenomic BRCA alterations that can predict chemotherapy resistance in breast and ovarian cancers. A new […]
Scientists have discovered a molecular pathway that may answer why some prostate cancers can resist an approved cancer drug. The […]
Written by Victoria Lee, Science Writer at Front Line Genomics In the fight against breast cancer, it’s useful to be […]
